header company

  • Home
  • Products
    • Our Products
    • β-Lactamases
    • β-Lactamase media plates
    • Lipases
    • Lipase Suicide Inhibitors
    • Peroxidases
    • Phospholipase D
    • Nitrile Hydratases
    • Tubulysins
    • Other Enzymes
  • Services
    • Our Services
    • Protein & Enzyme Engineering
    • Bioprocess Development
    • Final Formulation & Analysis
    • Industrial Manufacturing
  • Technology
    • In Vivo Recombination
    • CTAT - Enzymatic Drug Conjugation
  • Company
    • We are...
    • White Biotechnology
    • Management Team
    • Partners
    • Investors
    • Career
  • Partnering
    • Business Development
  • News
    • News
    • Meet Us
  • Contact
Print

EUCODIS Bioscience's Investors

EUCODIS Bioscience is a private company, backed up by institutional venture capital investors, founders, and private investors.

Investors in the Company include

arax Capital Partners

Logo gamma capital partners

 

Logo Wiener Wachstumsfonds

 

The Company has received significant support by the following Austrian and German public agencies: aws, FFG, ZIT and FNR.

Logo awsLogo FFGLogo ZIT

Fachagentur Nachwachsende Rohstoffe

 

 

bottom productcatalog

bottom productcatalog

bottom productcatalog

bottom productcatalog

Latest News

EUCODIS Bioscience developed enzyme and enzymatic production method for PrEP Biopharm drug...

Sep/04/2017

Eucodis starts commercialization of tubulysin A and B

Jan/23/2017

Meet Us

COSMET'AGORA 2019, Paris, France, January 15-16

BIO-Europe Spring 2019, Vienna, Austria, March 25-27

Career

Online Application

Apr/24/2017
  • Contact
  • Downloads
  • Impressum